Kniha Tumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers Ankit Jain

Tumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers

Basics to Emerging Applications

Jazyk: Angličtina
Vazba: Brožovaná
Vydavatel: Elsevier Science
Dostupnost: U nakladatele na objednávku
Odesíláme za 28-34 dnů
4 134
Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not...

Informace o knize

Jazyk
Angličtina
Vazba
Kniha - Brožovaná
Vydáno
2024
Stránek
240
EAN
9780443291258
ISBN
044329125X
Enbook ID
45116602
Vydavatel
Hmotnost
450
Rozměry
191 x 235

Kompletní popis

Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints the scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumour targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters this book provides basics and advances in stimuli-responsive vesicular carriers for tumour targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts. With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumours, drug delivery approaches, and associated challenges, it helps the readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer It is a valuable resource for cancer researchers, oncologists, clinicians, and members of biomedical field who needs to understand the potential of multifunctional nanoparticles in cancer drug delivery, diagnosis, and treatment. Addresses the unmet needs and challenges confronted by nanotechnologists to foster collaboration of biologists, chemists, physicists, bioengineers, and cliniciansProvides an explicit account of vital aspects of PEGylation of these carriers and challenges for effective tumor targetingPresents a need-of-hour discussion over regulatory concerns, clinical trials, and patents

Mohlo by vás zajímat

388

Rodin

Judith Cladel
812
1 081

Modern Painting

George Augustus Moore
171
593
476
305

Zákaznicí kteří koupili tuto knihu koupili také

688

Future Sounds

Christoph Dallach
359
1 433
912

Berlin - New York

Alexander Osang
300